Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of β-cell-dependent contrast enhancement in the pancreas
Year: 2020
Type: article
Abstract: Global rates of diabetes mellitus are increasing, and treatment of the disease consumes a growing proportion of healthcare spending across the world. Pancreatic β-cells, responsible for insulin production, decline in mass in type 1 and, to a more limited degree, in type 2 diabetes. However, the extent and rate of loss in both diseases differs between patients resulting in the need for the development of novel diagnostic tools, which could quantitatively assess changes in mass of β-cells over time and potentially lead to earlier diagnosis and improved treatments. Exendin-4, a potent analogue of glucagon-like-peptide 1 (GLP-1), binds to the receptor GLP-1R, whose expression is enriched in β-cells. GLP-1R has thus been used in the past as a means of targeting probes for a wide variety of imaging modalities to the endocrine pancreas. However, exendin-4 conjugates designed specifically for MRI contrast agents are an under-explored area. In the present work, the synthesis and characterization of an exendin-4-dota(ga)-Gd(iii) complex, GdEx, is reported, along with its in vivo behaviour in healthy and in β-cell-depleted C57BL/6J mice. Compared to the ubiquitous probe, [Gd(dota)]-, GdEx shows selective uptake by the pancreas with a marked decrease in accumulation observed after the loss of β-cells elicited by deleting the microRNA processing enzyme, DICER. These results open up pathways towards the development of other targeted MRI contrast agents based on similar chemistry methodology.
Source: Dalton Transactions
DOI: 10.1039/d0dt00332h
Language: English
Subfield: Materials Chemistry
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
Awards: Assessment of pulmonary vascular remodelling and right ventricular hypertrophy using Arg-Gly-Asp radioligand positron emission tomography, G130968091, G1635243398, Genetic and nutritional control of pancreatic beta cell identity., Potential role of Zip12 in regulation of hypoxia-induced pulmonary hypertension, Understanding pancreatic beta cell dysfunction in diabetes., Roles of GWA genes in controlling pancreatic beta cell function and mass., G2040450235, Control of glucagon secretion by AMPK and related kinases., G3555667338, AMPK-mediated regulation and roles of miR-125b and miR-184 in pancreatic beta-cell function., G4781795914, Investigation of selective HDAC6 inhibitor, C1A, as a treatment for pulmonary arterial hypertension, All-optical deconstruction of the islet wiring patterns underlying insulin secretion in health and disease, Targeting etiologic molecular mechanisms to treat human diabetes, G5675939615, The impact of long non-coding RNA at the Pax6 locus on beta cell identity and function, Defining the molecular and physiological mechanisms of pancreatic islet dysfunction which lead to type 2 diabetes, New 'Smart' Dual-Modal MR/PET Probes for Zinc Sensing Applications, Understanding pancreatic beta cell connectivity, Molecular mechanisms linking Sorcin to pancreatic beta cell lipotoxicity and ER Ca2+ stores., Roles of the type 2 diabetes (T2D)-associated gene C2cd4a in regulating glucose homeostasis in the mouse, G9000168923
OpenAlex ID: W3010754172